SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001174947-19-000605
Filing Date
2019-04-26
Accepted
2019-04-26 11:18:22
Documents
9
Period of Report
2019-06-13
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A c519624_def14a.htm DEF 14A 569446
2 GRAPHIC c519624_img1.jpg GRAPHIC 23418
3 GRAPHIC c519624_img2.jpg GRAPHIC 11834
4 GRAPHIC c519624_img3.jpg GRAPHIC 15636
5 GRAPHIC c519624_img4.jpg GRAPHIC 7511
6 GRAPHIC proxy_001.jpg GRAPHIC 199368
7 GRAPHIC proxy_002.jpg GRAPHIC 158594
8 GRAPHIC proxy_003.jpg GRAPHIC 275833
9 GRAPHIC proxy_004.jpg GRAPHIC 337757
  Complete submission text file 0001174947-19-000605.txt   1990087
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38599 | Film No.: 19770233
SIC: 2834 Pharmaceutical Preparations